Patterson W, Young N, Holzhausen E, Lurmann F, Liang D, Walker D
Environ Pollut. 2025; 368:125692.
PMID: 39864653
PMC: 11859754.
DOI: 10.1016/j.envpol.2025.125692.
Sato S, Iino C, Sasada T, Soma G, Furusawa K, Yoshida K
JGH Open. 2024; 8(12):e70043.
PMID: 39713746
PMC: 11659511.
DOI: 10.1002/jgh3.70043.
Schenker R, Machle C, Allayee H, Lurmann F, Patterson W, Kohli R
Ecotoxicol Environ Saf. 2024; 286:117234.
PMID: 39454357
PMC: 11578286.
DOI: 10.1016/j.ecoenv.2024.117234.
Sato S, Iino C, Sasada T, Soma G, Furusawa K, Yoshida K
Genes (Basel). 2024; 15(9).
PMID: 39336763
PMC: 11430940.
DOI: 10.3390/genes15091172.
Schenker R, Machle C, Schmidt K, Allayee H, Kohli R, Goran M
Liver Int. 2024; 44(8):1768-1774.
PMID: 38634702
PMC: 11251846.
DOI: 10.1111/liv.15946.
Endotoxin biomarkers, hepatic fat fraction, liver volume and liver stiffness among adolescents at high-risk for non-alcoholic fatty liver disease: The HEROES study.
Perng W, Salmon K, Schenker R, Janssen R, Friedman J, Goran M
Pediatr Obes. 2023; 19(2):e13091.
PMID: 38084670
PMC: 10872969.
DOI: 10.1111/ijpo.13091.
Study protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent nonalcoholic fatty liver disease in Hispanic children.
Welsh J, Pyo E, Huneault H, Gonzalez Ramirez L, Alazraki A, Alli R
Contemp Clin Trials. 2023; 129:107170.
PMID: 37019180
PMC: 10734403.
DOI: 10.1016/j.cct.2023.107170.
Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity.
Barbieri E, Santoro N, Umano G
Front Endocrinol (Lausanne). 2023; 14:1062341.
PMID: 36733529
PMC: 9887046.
DOI: 10.3389/fendo.2023.1062341.
Molecular Screening via Sanger Sequencing of the Genetic Variants in Non-Alcoholic Fatty Liver Disease Subjects in the Saudi Population: A Hospital-Based Study.
Alsaif F, Al-Hamoudi W, Alotaiby M, Alsadoon A, AlMayouf M, Almadany H
Metabolites. 2022; 12(12).
PMID: 36557278
PMC: 9784496.
DOI: 10.3390/metabo12121240.
Association of rs738409 Polymorphism in Adiponutrin Gene with Liver Steatosis and Atherosclerosis Risk Factors in Greek Children and Adolescents.
Stasinou E, Emmanouilidou-Fotoulaki E, Kavga M, Sotiriadou F, Lambropoulos A, Fotoulaki M
Nutrients. 2022; 14(17).
PMID: 36079710
PMC: 9459993.
DOI: 10.3390/nu14173452.
Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity.
Calcaterra V, Magenes V, Vandoni M, Berardo C, Marin L, Bianchi A
Children (Basel). 2022; 9(8).
PMID: 36010064
PMC: 9406958.
DOI: 10.3390/children9081174.
Association between rs738409 and rs2896019 single-nucleotide polymorphisms of phospholipase domain-containing protein 3 and susceptibility to nonalcoholic fatty liver disease in Greek children and adolescents.
Stasinou E, Argyraki M, Sotiriadou F, Lambropoulos A, Fotoulaki M
Ann Gastroenterol. 2022; 35(3):297-306.
PMID: 35599930
PMC: 9062843.
DOI: 10.20524/aog.2022.0706.
Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity.
Oses M, Cadenas-Sanchez C, Medrano M, Galbete A, Miranda-Ferrua E, Ruiz J
Pediatr Obes. 2022; 17(9):e12917.
PMID: 35394122
PMC: 9541234.
DOI: 10.1111/ijpo.12917.
Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.
Schmidt K, Jones R, Rios C, Corona Y, Berger P, Plows J
J Nutr. 2022; 152(7):1655-1665.
PMID: 35218194
PMC: 9258557.
DOI: 10.1093/jn/nxac046.
Leveraging health systems data to characterize a large effect variant conferring risk for liver disease in Puerto Ricans.
Belbin G, Rutledge S, Dodatko T, Cullina S, Turchin M, Kohli S
Am J Hum Genet. 2021; 108(11):2099-2111.
PMID: 34678161
PMC: 8595966.
DOI: 10.1016/j.ajhg.2021.09.016.
Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States.
Chai W, Eaton S, Rasmussen H, Tao M
Biomedicines. 2021; 9(9).
PMID: 34572279
PMC: 8472595.
DOI: 10.3390/biomedicines9091093.
Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren Study.
Cohen C, Perng W, Sauder K, Ringham B, Bellatorre A, Scherzinger A
J Pediatr. 2021; 237:50-58.e3.
PMID: 34171361
PMC: 8478817.
DOI: 10.1016/j.jpeds.2021.06.027.
Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity.
Jones R, Arenaza L, Rios C, Plows J, Berger P, Alderete T
Nutrients. 2021; 13(5).
PMID: 34065978
PMC: 8151324.
DOI: 10.3390/nu13051621.
Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.
Scapaticci S, DAdamo E, Mohn A, Chiarelli F, Giannini C
Front Endocrinol (Lausanne). 2021; 12:639548.
PMID: 33889132
PMC: 8056131.
DOI: 10.3389/fendo.2021.639548.
Catch-up growth in juvenile rats, fat expansion, and dysregulation of visceral adipose tissue.
Lizarraga-Mollinedo E, Carreras-Badosa G, Xargay-Torrent S, Remesar X, Mas-Pares B, Prats-Puig A
Pediatr Res. 2021; 91(1):107-115.
PMID: 33654281
DOI: 10.1038/s41390-021-01422-9.